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Abstract
Background: The functional changes associated with endothelial senescence may be involved in
human aging and age-related vascular disorders. Since the inflammatory cytokine interleukin (IL-)1
inhibits endothelial growth, we evaluated the expression of IL-1α, IL-1β and their antagonist, the
IL-1 receptor antagonist (IL-1ra), in endothelial in vitro senescence and quiescence. We also
examined the expression of IL-1α in human senescent and progeric fibroblasts.
Results:  We found that the overexpression of IL-1α specifically characterizes endothelial
senescence. No modulation of this cytokine was observed in endothelial quiescence and in
senescent or progeric human fibroblasts. The expression of IL-1β and IL-1ra was also assessed and
found not to be affected by senescence.
Conclusion: Our results indicate that a dysfunction of the cytokine network associates with aging
and point to a specific role of IL-1α in endothelial senescence.
Introduction
The endothelium is a dynamic, heterogeneous, dissemi-
nated organ that possesses vital secretory, synthetic, meta-
bolic and immunologic functions. In vivo endothelial cells
(EC) represent a large population of quiescent cells lining
the vessels. Macrovascular EC rarely divide with a turnover
rate of approximately once every three years [1], although
replication is increased under conditions that favor
atherogenesis, such as hypertension, high cholesterol lev-
els and anatomical branch points. In vitro, EC have a
finite number of cell replication reaching replicative
senescence [2]. This cessation of cell division is accompa-
nied by a specific set of changes in cell function, morphol-
ogy and gene expression [3,1] that may contribute to age-
associated diseases, including atherosclerosis. Interest-
ingly, vascular endothelial cells with senescence-associ-
ated phenotypes have been detected in the atherosclerotic
regions of human aorta [4] and coronary arteries [5].
Accordingly, multiple baloon endothelial denudation in
non-atheromatous rabbit carotid arteries promoted the
accumulation of senescent cells in the arterial wall [6].
Endothelial senescence is modulated in part by the
inflammatory cytokine interleukin (IL-)1α [2,7]. IL-1 and
its family members are expressed in human atheroscle-
rotic vessels, mainly in the endothelium [8]. It is notewor-
thy that EC replicative senescence and IL-1 have been
associated with atherosclerosis.
Although senescence and quiescence have a common
denominator represented by the inhibition of cell growth,
the two processes are different, because senescence is char-
Published: 06 April 2006
Immunity & Ageing 2006, 3:4 doi:10.1186/1742-4933-3-4
Received: 28 October 2005
Accepted: 06 April 2006
This article is available from: http://www.immunityageing.com/content/3/1/4
© 2006 Mariotti et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Immunity & Ageing 2006, 3:4 http://www.immunityageing.com/content/3/1/4
Page 2 of 6
(page number not for citation purposes)
acterized by an irreversible growth arrest as well as by a
specific gene expression profile [3].
This paper addresses the relation between IL-1α, IL-1β
and IL-1ra expression and macrovascular endothelial cell
quiescence and senescence. We also examined the expres-
sion of IL-1α in human senescent and progeric fibroblasts.
We conclude that the overexpression of IL-1α is a specific
marker of in vitro endothelial senescence.
Methods
Cell culture
Human umbilical vein EC (HUVEC) were cultured in
M199 containing 10% fetal calf serum (FCS), Endothelial
Cell Growth Supplement (150 µg/ml) and heparin (5 U/
ml) on 2% gelatin coated dishes. All culture reagents were
from Gibco. Human fibroblasts from progeric individuals
(GM0498, 3 year-old male; GM2037, 13 year old male)
and age-matched controls (AG6917, 3 year-old male;
AG3513, 13 year old male) were from ATCC and cultured
in D-MEM containing 20% FCS. Human dermal fibrob-
lasts were isolated and propagated in D-MEM with 10%
FCS until they reached cellular senescence [9].
The population doublings (PD) were calculated as log2
(number of cells at time of subculture/number of cells
plated). The senescent phenotype was assessed by evaluat-
ing the senescence-associated (SA)-beta galactosidase
activity as described [10].
Northern blot and RT-PCR analysis
HUVEC were rinsed with phosphate buffered saline and
lyzed in RNAzol (Gibco). PolyA+ RNA was purified on oli-
godT columns, electrophoresed on a 1% agarose gel con-
taining 2.2 M formaldehyde, capillary blotted onto nylon
membranes and UV crosslinked. IL-1α and GAPDH
cDNAs were labelled with a random primer labeling kit
(Ambion). Filters were hybridized in 0.5 M sodium phos-
phate (pH 7.2) containing 7% SDS, 1 mM EDTA and 20%
formamide at 65°C for 20 h and extensively washed at
high stringency before autoradiography. The results were
quantitated by densitometry. To establish whether com-
parable amounts of RNA had been loaded, the ratio
GAPDH/IL-1α was evaluated. For RT-PCR, 1 µg of total
RNA was reverse transcribed and PCR amplification was
carried out using 1/50 of the final RT reaction. Each
amplification cycle consisted of 30 sec at 95°C, 30 sec at
52°C and 1 min at 72°C using 30 pmol of each primer.
The reaction was stopped after 15 or 30 cycles. One fifth
of the reaction mix was separated on a 1% agarose gel. The
primers used to amplify IL-1β are the following: 5'-
GACTTGTTCTTTGAAGTCGAT-3' (sense) and 5'-
TAGAGTGGGCTTATCATCTTT-3' (reverse). The primers
for IL-1ra are: 5'-ATGGAAATCTGCAGAGGCCTCCG-
CAGT-3' (sense) and 5'-CTGGTCAGCTTCCATCGCTGT-
GCAGAGGAA-3' (antisense). The sequence of the
GAPDH primers has been published [2].
Western blot
HUVEC were lysed in 10 mM Tris-HCl (pH 7.4) contain-
ing 3 mM MgCl2, 10 mM NaCl, 0,1% SDS, 0,1% Triton X-
100, 0,5 mM EDTA and protein inhibitors, separated on
15% SDS-PAGE and transferred to nitrocellulose sheets.
Western blot analysis was performed using polyclonal
goat antibodies against IL-1α (Santa Cruz-TebuBio). Sec-
ondary antibodies were labeled with horseradish peroxi-
dase (Amersham Pharmacia Biotech). The SuperSignal
chemiluminescence kit (Pierce) was used to detect immu-
noreactive proteins following the manufacturer's instruc-
tions. The blots were stripped and incubated with an anti-
actin antibody (Santa Cruz – Tebu-bio) to show that com-
parable amounts of protein were loaded per lane. Densit-
ometric analysis was performed to better quantitate the
results. All the western blots have been repeated at least
three times on cell extracts from different experiments.
IL-1α expression in HUVEC Figure 1
IL-1α expression in HUVEC. (A) 3 µg of polyA+ RNA 
were utilized for Northern analysis. GAPDH hybridization 
shows that comparable amounts of RNA were loaded per 
lane. P: proliferating cells (PD 20); Q: quiescent cells (PD 20). 
PD indicates the number of population doublings undergone 
by HUVEC (from young -PD 13- to senescent – PD 45-). (B) 
Cell lysates (450 µg) from proliferating vs quiescent HUVEC 
were separated by a 15% SDS-PAGE and western blot was 
performed as described in the methods. After stripping, the 
blot was incubated with an anti-actin antibody to show that 
comparable amounts of protein were loaded per lane. P: pro-
liferating cells; Q: quiescent cells, both at PD 20.Immunity & Ageing 2006, 3:4 http://www.immunityageing.com/content/3/1/4
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Results
IL-1α levels in proliferating vs quiescent HUVEC
On culture plates, HUVEC grow until they form a perfect
monolayer. At this stage, cells stop growing and become
quiescent. This pattern correlates with the arrest of thymi-
dine incorporation (not shown). Since IL-1α inhibits
endothelial proliferation, we evaluated whether IL-1α was
modulated in actively proliferating versus quiescent
HUVEC, both at PD 20. PolyA+ RNA was separated by
electrophoresis and Northern blot was performed. We
detected no modulation of IL-1α RNA in quiescent vs pro-
liferating cells (Fig. 1A). Accordingly, the protein levels of
IL-1 were comparable in quiescent and proliferating cells
(Fig. 1B). Similar results were obtained in HUVEC cells
when quiescence was reached by growth factor with-
drawal (not shown).
IL-1s expression in HUVEC cells at various PD
Since cellular senescence correlates with the decline of the
proliferating rate and an antisense against IL-1α extends
endothelial lifespan [2], we evaluated IL-1α levels in
HUVEC at different PD. As shown in figure 1A, a gradual
increase of IL-1α mRNA paralleled the increase of PD, as
detected by Northern blot performed on polyA+ RNA.
Accordingly, we detected higher amounts of IL-1α in
senescent (PD 45) than in young (PD 15) cells by western
analysis (Fig. 2).
Because i) IL-1α shares many activities with IL-1β and ii)
their activities are antagonized by the IL-1 receptor antag-
onist (IL-1ra), we determined the expression of the mem-
bers of the IL-1 family, i.e. IL-1α, IL-1β and IL-1ra by RT-
PCR in HUVEC at different PDs. To provide a better quan-
tification, the PCR reaction was stopped after 15 or 30
cycles. In both conditions, we found no significant mod-
ulation of the total amounts of IL-1β and IL-1ra in young
and senescent endothelial cells, while we confirmed the
induction of IL-1α expression (Fig. 3).
IL-1s in young, senescent and progeric human fibroblasts
To determine whether the relationship between IL-1s and
senescence occurred also in fibroblasts, we examined
young and senescent human dermal fibroblasts for their
expression of IL-1α by Northern on polyA+ RNA and west-
ern blot and found no differences (Fig. 4A and 4B). Prog-
eria is a rare premature aging syndrome which is
characterized by external stigmata of aging and death
within the fierst two decades of life [11]. We therefore
evaluated IL-1α expression in dermal fibroblasts derived
from progeric individuals. Figure 4A and 4B show that IL-
1α mRNA and protein levels are not significantly modu-
lated in progeric vs age-matched dermal fibroblasts.
By RT-PCR, we show that no modulation occurs in the
steady state levels of IL-1β and IL-1ra (Fig. 5) in senescent
and progeric fibroblasts.
Discussion
The results of the present study indicate that the overex-
pression of IL-1α specifically characterizes endothelial
senescence. No modulation of this cytokine was observed
in endothelial quiescence and in senescent or progeric
human fibroblasts.
IL-1α shares many activity with IL-1β, since they act by
binding to a common receptor, the type I IL-1 receptor
[12]. A third member of the family, the IL-1 receptor
antagonist (IL-1ra), also binds to the type I IL-1 receptor
and blocks the receptor, preventing the action of the ago-
nist IL-1s [12]. In senescent endothelial cells we did not
detect any modulation of the mRNA levels for IL-1β and
IL-1ra. We therefore propose that IL-1α could be used as a
marker of endothelial senescence. IL-1α causes multiple
responses in vascular endothelial cells including inhibi-
tion of cell proliferation [13], induction of adhesion mol-
ecules which bind leukocytes [14] and promotion of
thrombus formation [15]. Indeed, in vitro, IL-1α overex-
pression has been linked to endothelial lifespan and to
several dysfunctions [2]. It is noteworthy that senescent
endothelial cells are found on the surface of atheroscle-
rotic plaques [5] and that IL-1 is produced by endothe-
lium on aged coronary arteries [8].
IL-1α total amounts in young and senescent HUVEC Figure 2
IL-1α total amounts in young and senescent HUVEC. 
Cell lysates (350 µg) from young and senescent HUVEC 
were separated by a 15% SDS-PAGE and western blot was 
performed as described. After stripping, the blot was incu-
bated with an anti-actin antibody to show that comparable 
amounts of protein were loaded per lane. PD 15: young 
HUVEC; PD 45: senescent HUVEC.Immunity & Ageing 2006, 3:4 http://www.immunityageing.com/content/3/1/4
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Increased vascular production of pro-inflammatory
cytokines may contribute to the increased plasma levels of
these mediators in aging [16,17]. We propose that the
upregulation of IL-1 can be linked to the activation of var-
ious pathophysiological programs that underlie the com-
plex biological phenomenon described as "vascular
aging". Proinflammatory status of aged arteries may shift
the intravascular environment from a hemodynamically
stable state to a pro-coagulant, pro-oxidant state which
may favour an exaggerated response to vessel injury, pro-
moting the development of ischemic heart disease in the
elderly.
IL-1ra allelic polymorphisms affect replicative lifespan of
human EC [10]. The polymorphism IL-1RN*2*2, which
decreases the levels of IL-1ra, was associated with
increased numbers of senescent endothelial cells and an
inhibition of proliferation, while the addition of IL-1ra
restored the proliferative potential of the cells and
extended their lifespan [10]. Because endothelial turnover
is enhanced under conditions that favour atherogenesis
thus leading to a senescent phenotype, it is noteworthy
that the IL-1RN*2 allele is associated with atherosclerotic
coronary disease [18]. All together, these data suggest that
IL-1ra may prevent the senescent-promoting effects of IL-
1 in the endothelium.
We did not detect any modulation of the steady state lev-
els of IL-1s in in vitro aged human dermal and in progeric
fibroblasts. This is in agreement with a previous study per-
formed on IMR-90 cells, demonstrating that the human
diploid fibroblast senescence pathway is independent of
IL-1α mRNA levels [19]. On the contrary, expression of IL-
1β and IL-1ra was induced in senescent mouse embryonic
fibroblasts [20]. Interestingly, the IL-1ra-/- mice presented
early mortality compared to wild-type mice and acceler-
ated senescence was observed in IL-1ra deficient fibrob-
lasts [21]. All together these data indicate that a
dysfunction of the cytokine network associates with aging
and point to a specific role of IL-1α in endothelial senes-
cence.
IL-1α expression in young, senescent and progeric human  dermal fibroblasts Figure 4
IL-1α expression in young, senescent and progeric 
human dermal fibroblasts. (A) 3 µg of polyA+ RNA were 
utilized for Northern analysis. GAPDH hybridization shows 
that comparable amounts of RNA were loaded. PD 9: young 
fibroblasts; PD 43: senescent fibroblasts. Two different prog-
eric cell types and age-matched controls have been utilized as 
described. Progeric and control #1: GM0498 and AG6917, 
respectively; progeric and control #2: GM2037 and AG3513, 
respectively. (B) Cell lysates (250 µg) from young, senescent 
and progeric (#1: GM0498 and AG6917) dermal fibroblasts 
were separated by a 15% SDS-PAGE and western blot was 
performed. After stripping, the blot was incubated with an 
anti-actin antibody to show that comparable amounts of pro-
tein were loaded per lane. PD 9: young fibroblasts; PD 43: 
senescent fibroblasts; progeric and control #1: GM0498 and 
AG6917.
IL-1α, IL-1β and IL-1ra expression in young and senescen- tHUVEC Figure 3
IL-1α, IL-1β and IL-1ra expression in young and 
senescentHUVEC. RNA was extracted from HUVEC at 
different PD (13, 31,54). RT-PCR was performed using spe-
cific primers for IL-1α, IL-1β and IL-1ra. PCR amplification 
was stopped after 15 and 30 cycles to provide a better quan-
tification of the results. GAPDH was utilized to show that 
similar amounts of RNA had been reverse-transcribed.Publish with BioMed Central    and   every 
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Abbreviations
interleukin-1 IL-1
IL-1 receptor antagonist IL-1ra
endothelial cells EC
human umbilical vein EC HUVEC
reverse transcription- polymerase chain reaction RT-PCR
References
1. Foreman KE, Tang J: Molecular mechanisms of replicative
senescence in endothelial cells.  Exp Gerontol 2003,
38:1251-1257.
2. Maier JAM, Voulalas P, Roeder D, Maciag T: Extension of the life-
span of human endothelial cells by an interleukin-1 alpha
antisense oligomer.  Science 1990, 249:1570-1574.
3. Shelton DN, Chang E, Whittier PS, Choi D, Funk WD: Microarray
analysis of replicative senescence.  Curr Biol 1999, 9:939-945.
4. Vasile E, Tomita Y, Brown LF, Kocher O, Dvorak HF: Differential
expression of thymosin beta-10 by early passage and senes-
cent vascular endothelium is modulated by VPF/VEGF: evi-
dence for senescent endothelial cells in vivo at sites of
atherosclerosis.  FASEB J 2001, 15:458-466.
5. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I:
Endothelial cell senescence in human atherosclerosis: role of
telomere in endothelial dysfunction.  Circulation 2002,
105:1541-1544.
6. Fenton M, Barker S, Kurz DJ, Erusalimsky JD: Cellular senescence
after single and repeated balloon catheter denudations of
rabbit carotid arteries.  Arterioscler Thromb Vasc Biol 2001,
21:220-226.
7. Garfinkel S, Brown S, Wessendorf JH, Maciag T: Post-transcrip-
tional regulation of interleukin 1 alpha in various strains of
young and senescent human umbilical vein endothelial cells.
Proc Natl Acad Sci U S A 1994, 91:1559-1563.
8. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G: Aging-induced
proinflammatory shift in cytokine expression profile in coro-
nary arteries.  FASEB J 2003, 17:1183-1185.
9. Comi P, Chiaramonte R, Maier JAM: Senescence-dependent reg-
ulation of type 1 plasminogen activator inhibitor in human
vascular endothelial cells.  Exp Cell Res 1995, 219:304-308.
10. Dewberry RM, Crossman DC, Francis SE: Interleukin-1 receptor
antagonist (IL-1RN) genotype modulates the replicative
capacity of human endothelial cells.  Circ Res 2003,
92:1285-1287.
11. Beauregard S, Gilchrest BA: Syndromes of premature aging.
Dermatol Clin 1987, 5:109-121.
12. Fantuzzi G: Lessons from interleukin-deficient mice: the inter-
leukin-1 system.  Acta Physiol Scand 2001, 173(1):5-9.
13. Cozzolino F, Torcia M, Aldinucci D, Ziche M, Almerigogna F, Bani D,
Stern DM: Interleukin 1 is an autocrine regulator of human
endothelial cell growth.  Proc Natl Acad Sci U S A 1990,
87:6487-6491.
14. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr:
Interleukin 1 (IL-1) induces biosynthesis and cell surface
expression of procoagulant activity in human vascular
endothelial cells.  J Exp Med 1984, 160:618-623.
15. Schorer AE, White JG: Interleukin 1 enhances arterial throm-
bogenicity in vitro.  Thromb Res 1989, 56:515-22.
16. Gerli R, Monti D, Bistoni O, Mazzone AM, Peri G, Cossarizza A, Di
Gioacchino M, Cesarotti ME, Doni A, Mantovani A, Franceschi C,
Paganelli R: Chemokines, sTNF-Rs and sCD30 serum levels in
healthy aged people and centenarians.  Mech Ageing Dev 2000,
121:37-46.
17. Straub RH, Cutolo M, Zietz B, Scholmerich J: The process of aging
changes the interplay of the immune, endocrine and nervous
systems.  Mech Ageing Dev 2001, 122:1591-1611.
18. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jef-
fery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC: Inter-
leukin-1 receptor antagonist gene polymorphism and
coronary artery disease.  Circulation 1999, 99:861-866.
19. Garfinkel S, Wessendorf JH, Hu X, Maciag T: The human diploid
fibroblast senescence pathway is independent of interleukin-
IL-1β and IL-1ra expression in young, senescent and progeric  human dermal fibroblasts Figure 5
IL-1β and IL-1ra expression in young, senescent and 
progeric human dermal fibroblasts. RNA was extracted 
to perform an RT-PCR using specific primers for IL-1β and 
IL-1ra. GAPDH was utilized to show that comparable 
amounts of RNA had been reverse-transcribed. 30 cycles of 
PCR were performed. PD 9: young fibroblasts; PD 43: senes-
cent fibroblasts; progeric and control #1: GM0498 and 
AG6917.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Immunity & Ageing 2006, 3:4 http://www.immunityageing.com/content/3/1/4
Page 6 of 6
(page number not for citation purposes)
1 alpha mRNA levels and tyrosine phosphorylation of FGFR-
1 substrates.  Biochim Biophys Acta 1996, 1314:109-119.
20. Uekawa N, Nishikimi A, Isobe K, Iwakura Y, Maruyama M: Involve-
ment of IL-1 family proteins in p38 linked cellular senescence
of mouse embryonic fibroblasts.  FEBS Lett 2004, 575:30-34.
21. Irikura VM, Lagraoui M, Hirsh D: The epistatic interrelationships
of IL-1, IL-1 receptor antagonist, and the type I IL-1 recep-
tor.  J Immunol 2002, 169:393-398.